Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2017 (2017), Article ID 1017621, 7 pages
https://doi.org/10.1155/2017/1017621
Research Article

Genetic Polymorphisms of IL17 and Chagas Disease in the South and Southeast of Brazil

1Post Graduation Program of Biosciences and Physiopathology, Department of Analysis Clinical and Biomedicine, Maringa State University, Maringa, PR, Brazil
2Laboratory of Immunogenetics, Department of Molecular Biology, Medical School, São José do Rio Preto, SP, Brazil
3Laboratory of Immunogenetics, Department of Basic Health Sciences, Maringa State University, Maringa, PR, Brazil
4Department of Medical Clinic, Londrina State University, Londrina, PR, Brazil
5Department of Cardiology and Cardiovascular Surgery, Medical School, São José do Rio Preto, SP, Brazil

Correspondence should be addressed to Jeane Eliete Laguila Visentainer; moc.liamg@reniatnesivlej

Received 23 September 2016; Accepted 30 January 2017; Published 2 April 2017

Academic Editor: Margarete D. Bagatini

Copyright © 2017 Pâmela Guimarães Reis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. WHO, “Chagas disease (American trypanosomiasis)—Facts Sheet,” in The Weekly Epidemiological Records, vol. 87, pp. 519–522, World Health Organization, Geneva‎, Switzerland, 2012. View at Google Scholar
  2. PAHO, Chagas Disease (American Trypanosomiasis), Regional Office for the Americas of the World Healthg Organization, Washington, DC, USA, 2014.
  3. A. Moncayo, “Chagas disease: current epidemiological trends after the interruption of vectorial and transfusional transmission in the southern cone countries,” Memorias do Instituto Oswaldo Cruz, vol. 98, no. 5, pp. 577–591, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. A. M. Macedo, C. R. Machado, R. P. Oliveira, and S. D. J. Pena, “Trypanosoma cruzi: genetic structure of populations and relevance of genetic variability to the pathogenesis of chagas disease,” Memorias do Instituto Oswaldo Cruz, vol. 99, no. 1, pp. 1–12, 2004. View at Google Scholar · View at Scopus
  5. A. Rassi Jr., A. Rassi, and J. A. Marin-Neto, “Chagas disease,” The Lancet, vol. 375, no. 9723, pp. 1388–1402, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Rassi, A. Rassi, and J. Marcondes de Rezende, “American Trypanosomiasis (Chagas Disease),” Infectious Disease Clinics of North America, vol. 26, no. 2, pp. 275–291, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Rassi Jr., A. Rassi, and J. A. Marin-Neto, “Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification,” Memorias do Instituto Oswaldo Cruz, vol. 104, no. 1, pp. 152–158, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. C. M. Ayo, M. M. D. O. Dalalio, J. E. L. Visentainer et al., “Genetic susceptibility to chagas disease: an overview about the infection and about the association between disease and the immune response genes,” BioMed Research International, vol. 2013, Article ID 284729, 13 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. T. A. Moseley, D. R. Haudenschild, L. Rose, and A. H. Reddi, “Interleukin-17 family and IL-17 receptors,” Cytokine and Growth Factor Reviews, vol. 14, no. 2, pp. 155–174, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. N. Hizawa, M. Kawaguchi, S.-K. Huang, and M. Nishimura, “Role of interleukin-17F in chronic inflammatory and allergic lung disease,” Clinical and Experimental Allergy, vol. 36, no. 9, pp. 1109–1114, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Korn, E. Bettelli, M. Oukka, and V. K. Kuchroo, “IL-17 and Th17 cells,” Annual Review of Immunology, vol. 27, pp. 485–517, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. J. L. Espinoza, A. Takami, K. Nakata et al., “A genetic variant in the IL-17 promoter is functionally associated with acute graft-versus-host disease after unrelated bone marrow transplantation,” PLoS ONE, vol. 6, no. 10, Article ID e26229, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Kawaguchi, D. Takahashi, N. Hizawa et al., “IL-17F sequence variant (His161Arg) is associated with protection against asthma and antagonizes wild-type IL-17F activity,” Journal of Allergy and Clinical Immunology, vol. 117, no. 4, pp. 795–801, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. G. B. N. Nordang, M. K. Viken, J. E. Hollis-moffatt et al., “Association analysis of the interleukin 17A gene in Caucasian rheumatoid arthritis patients from Norway and New Zealand,” Rheumatology, vol. 48, no. 4, pp. 367–370, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. J. M. V. Zacarias, E. Â. Sippert, P. Y. Tsuneto, J. E. L. Visentainer, C. D. O. E. Silva, and A. M. Sell, “The influence of interleukin 17A and IL17F polymorphisms on chronic periodontitis disease in Brazilian patients,” Mediators of Inflammation, vol. 2015, Article ID 147056, 8 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. X. Wu, Z. Zeng, B. Chen et al., “Association between polymorphisms in interleukin-17A and interleukin-17F genes and risks of gastric cancer,” International Journal of Cancer, vol. 127, no. 1, pp. 86–92, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Wang, Y. Jiang, Y. Zhang et al., “Association analysis of IL-17A and IL-17F polymorphisms in Chinese han women with breast cancer,” PLoS ONE, vol. 7, no. 3, Article ID e34400, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. D. A. L. Rodriguez, L. E. Echeverría, C. I. González, and J. Martin, “Investigation of the role of IL17A gene variants in Chagas disease,” Genes and Immunity, vol. 16, no. 8, pp. 536–540, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. O. P. Dutra, H. W. Besser, H. Tridapalli et al., “Sociedade Brasileira de Cardiologia, II Brazilian guideline for severe heart disease,” Arquivos Brasileiros de Cardiologia, vol. 87, no. 2, pp. 223–232, 2006. View at Google Scholar
  20. F. C. Parra, R. C. Amado, J. R. Lambertucci, J. Rocha, C. M. Antunes, and S. D. J. Pena, “Color and genomic ancestry in Brazilians,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 1, pp. 177–182, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. S. W. M. John, G. Weitzner, R. Rozen, and C. R. Scriver, “A rapid procedure for extracting genomic DNA from leukocytes,” Nucleic Acids Research, vol. 19, no. 2, article 408, 1991. View at Publisher · View at Google Scholar · View at Scopus
  22. Sun Wei Guo and E. A. Thompson, “Performing the exact test of Hardy-Weinberg proportion for multiple alleles,” Biometrics, vol. 48, no. 2, pp. 361–372, 1992. View at Publisher · View at Google Scholar · View at Zentralblatt MATH · View at Scopus
  23. X. Solé, E. Guinó, J. Valls, R. Iniesta, and V. Moreno, “SNPStats: a web tool for the analysis of association studies,” Bioinformatics, vol. 22, no. 15, pp. 1928–1929, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. P. M. da Matta Guedes, F. R. S. Gutierrez, F. L. Maia et al., “IL-17 produced during Trypanosoma cruzi infection plays a central role in regulating parasite-induced myocarditis,” PLoS Neglected Tropical Diseases, vol. 4, no. 2, article e604, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Miyazaki, S. Hamano, S. Wang, Y. Shimanoe, Y. Iwakura, and H. Yoshida, “IL-17 is necessary for host protection against acute-phase Trypanosoma cruzi infection,” The Journal of Immunology, vol. 185, no. 2, pp. 1150–1157, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. L. M. D. Magalhães, F. N. A. Villani, M. D. C. P. Nunes, K. J. Gollob, M. O. C. Rocha, and W. O. Dutra, “High interleukin 17 expression is correlated with better cardiac function in human Chagas disease,” The Journal of Infectious Diseases, vol. 207, no. 4, pp. 661–665, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Peng, B. Zhou, Y.-Y. Wang et al., “Analysis of IL-17 gene polymorphisms in Chinese patients with dilated cardiomyopathy,” Human Immunology, vol. 74, no. 5, pp. 635–639, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Rassi Jr., A. Rassi, W. C. Little et al., “Development and validation of a risk score for predicting death in Chagas' heart disease,” New England Journal of Medicine, vol. 355, no. 8, pp. 799–808, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. K. C. Faé, S. A. Drigo, E. Cunha-Neto et al., “HLA and β-myosin heavy chain do not influence susceptibility to Chagas' disease cardiomyopathy,” Microbes and Infection, vol. 2, no. 7, pp. 745–751, 2000. View at Publisher · View at Google Scholar · View at Scopus